Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-25
1993-09-07
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
052429415
ABSTRACT:
A method for treating circadian rhythm disorders is described. The method involves the administration of melatonin from about 6 hours to about 19 hours prior to when the normal sleep phase should begin, depending on whether a phase advance shift in circadian rhythms or a phase delay shift is desired. This is typically from about 4 hours to about 17 hours prior to the time of endogenous melatonin onset.
REFERENCES:
patent: 4600723 (1986-06-01), Short et al.
patent: 4665086 (1987-05-01), Short et al.
Gwinner, J. Comp. Physiol. 126: 123-129 (1978).
Arendt et al., Neurosci. Lett. 45: 317-321 (1984).
Arendt et al., CIBA Found. Symp. 117: 266-283 (1985).
Underwood, J. Pineal Res. 3: 187-196 (1986).
Arendt et al., Ergonomics 30: 1379-1393 (1987)
Mallo et al., Acta Endocrinol. 119: 474-480 (1988).
Armstrong et al., Experientia 45: 932-938 (1989).
Lewy Alfred J.
Sack Robert L.
Friedman S. J.
State of Oregon
LandOfFree
Methods of treating circadian rhythm disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating circadian rhythm disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating circadian rhythm disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488095